Multiple gene expression analysis reveals distinct differences between G2 and G3 stage breast cancers and correlations of PKCη with MDR1, MRP and LRP gene expression

British Journal of Cancer

Volumn 77, Issue 1, 1998, Pages 87-91

  Beck, J ^a,d   Bohnet, B ^a   Brugger D ^a   Bader, P ^a   Dietl, J ^a   Scheper, R J ^b   Kandolf, R ^a   Liu, C ^a   Niethammer, D ^a   Gekeler, V ^c  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ALTANA PHARMA AG   (Germany)

^d UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

Author keywords

Breast cancer; LRP; MDR; MDR1; MRP; PKC; Topoisomerase II

Indexed keywords

CYCLIN A; DNA TOPOISOMERASE (ATP HYDROLYSING); GLYCOPROTEIN P; ISOENZYME; PROTEIN KINASE C;

ADULT; AGED; ARTICLE; ASCITES CELL; BREAST CANCER; CANCER STAGING; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MULTIDRUG RESISTANCE; PRIORITY JOURNAL;

EID: 6844258220     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/bjc.1998.13     Document Type: Article

References (32)

1. Beck J, Handgretinger R, Dopfer R, Klingebiel T, Niethammer D and Gekeler V (1995) Expression of MDR1, MRP, topoisomerase 11α/β, and cyclin A in primary or relapsed states of acute lymphoblastic leukaemias. Br J Heamatol 89: 356-363
2. Beck J, Handgretinger R, Klingebiel T, Dopfer R, Schaich M, Ehninger G, Niethammer D and Gekeler V (1996a) Expression of PKC isozyme and MDR-associated genes in primary and relapsed state AML. Leukemia 10: 426-433
3. Beck J, Regele B, Brügger D, Dietl J, Scheper RJ, Niethammer D, Bader P, Hirsch HA and Gekeler V (1996b) Expression of genes (MDR1, MRP, LRP, topoisomerases, PKC isozymes) possibly invoked in drug resistance of ovarian carcinoma ascites cell aspirates. Proc Am Assoc Cancer Res 37: 309
4. Batist G, Tulpule A, Sinha BK, Katki AG, Meyers CE and Cowan KH (1986) Overexpression of a novel anionic glutathione transferase in multidrug-resistant human breast cancer cells. J Biol Chem 261: 15544-15549
5. Blobe GC, Obeid LM and Hannun YA (1994) Regulation of protein kinase C and role in cancer biology. Cancer Metast rev 13: 411-131
6. Bloom HJG and Richardson WW (1957) Histological grading and prognosis in breast cancer. Br J Cancer 11: 359-377
7. Chambers TC, Chalikonda I and Eilon G (1990a) Correlation of protein kinase C translocation, P-glycoprotein phosphorylation and reduced drug accumulation in multidrug resistant human KB cells. Biochem Biophys Res Commun 169: 253-259
8. Chambers TC, McAvoy EM, Jacobs JW and Eilon G (1990b) Protein kinase C phosphorylates P-glycoprotein in multidrug resistant human KB carcinoma cells. J Biol Chem 265: 7679-7686
9. Chaudhary PM and Roninson IB (1993) Induction of multidrug resistance in human cells by transient exposure to different chemotherapeutic drugs. J Natl Cancer Inst 85: 632-639
10. Chirgwin JM, Przybyla AE, MacDonald RJ and Rutter WJ (1979) Isolation of biological active ribonucleic acid from sources enriched in ribonuclease. Biochem 18: 5294-5299
11. Clifford SC, Neal DE and Lunec J (1996) Alterations in expression of the multidrug resistance-associated protein (MRP) gene in high-grade transitional cell carcinoma of the bladder. Br J Cancer 73: 659-666
12. Cordell J, Falini B, Erber W, Ghosh A, Ahdulaziz Z, MacDonald S, Pulford K, Stein H and Mayson D (1984) Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal anti-alkaline phosphatase (APAAP complexes). J Histochem Cytochem 32: 219-229
13. Gekeler V, Frese G, Diddens H and Probst H (1988) Expression of a P-glycoprotein gene is inducible in a multidrug-resistant human leukemia cell line. Biochem Biophys Res Commun 155: 754-760
14. Gekeler V, Beck J, Noller A, Wilisch A, Frese G, Neumann M, Handgretinger R, Ehninger G, Probst H and Niethammer D (1994) Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukeimas. Ann Heamatol 69: S19-24
15. Gekeler V, Boer R, Ise W, Sanders KH, Schächtele C and Beck J (1995) The specific bisindolylmaleimide PKC-inhibitor GF 109203X efficiently modulates MRP-associated multiple drug resistance. Biochem Biophys Res Commun 206: 119-126
16. Gekeler V, Boer R, Überall F, Ise W, Schubert C, Utz I, Hofmann J, Sanders KH, Schächtele C, Klemm K and Grunicke H (1996) Effects of the selective bisindolylmaleimide protein kinase C inhibitor GF109203X on P-glycoprotein mediated multidrug resistance. Br J Cancer 74: 897-905
17. Germann UA (1996) P-glycoprotein-a mediator of multidrug resistance in tumour cells. Eur J Cancer 32A: 927-944
18. Germann UA, Chambers TC, Ambudkar SV, Licht T, Cardarelli CO, Pastan I and Gottesman MM (1996) Characterization of phosphorylation-defective mutants of human P-glycoprotein expressed in mammalian cells. J Biol Chem 271: 1708-1716
19. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM and Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116-124
20. Greif H, Ben-Chaim J, Shimon T, Bechor E, Eldar H and Livneh E (1994) The protein kinase C-related PKC-L(η) gene product is localized in the cell nucleus. Mol Cell Biol 12: 1304-1311
21. Grunicke H, Hofmann J, Utz I and Überall F (1994) Role of protein kinases in antitumour drug resistance. Ann Heamatol 69: 1-6
22. Izquierdo MA, Scheffer GL, Flens MJ, Schroeijers AB, van der Valk P, Scheper RJ (1996) Major vault protein LRP-related multidrug resistance. Eur J Cancer 32A: 979-984
23. Loe DW, Deeley RG and Cole SP (1996) Biology of the multidrug resistance-associated protein, MRP. Eur J Cancer 32A: 945-957
24. Nitiss JL and Beck WT (1996) Antitopoisomerase drug action and resistance. Eur J Cancer 32A: 958-966
25. Pines J and Hunter T (1990) Human cyclin A is an adenovirus EIA-associated protein p60 and behaves differently from cyclin B. Nature 346: 760-763
26. Ro J, Sahin A, Ro JY, Fritsche H, Hortobagyi G and Blick M (1990) Immunohistochemical analysis of P-glycoprotein expression correlated with chemotherapy resistance in locally advanced breast cancer. Hum Pathol 21: 787-791
27. Sanfilippo O, Ronchi E, De Marco C, Di Franzo G and Silvestrini R (1991) Expression of P-glycoprotein in breast cancer tissue and in vitro resistance to doxorubicin and vincristine. Eur J Cancer 27: 155-158
28. Sato W, Yusa K, Naito M and Tsuruo T (1990) Staurosporine, a potent inhibitor of C-kinase, enhances drug accumulation in multidrug-resistant cells. Biochem Biophys Res Commun 173: 1252-1257
29. Scala S, Dickstein B, Regis J, Szallasi Z, Blumberg PM, Bates SE, Benjamin C, Osborn L, Lobb R and Harlan JM (1995) Bryostatin 1 affects P-glycoprotein phosphorylation but not function in multidrug-resistant human breast cancer cells. Clin Cancer Res 1: 1581-1587
30. Schneider J, Bak M, Efferth T, Kaufmann M, Mattern J and Volm M (1989) P-glycoprotein expression in treated and untreated human breast cancer. Br J Cancer 60: 815-818
31. Silvestrini R and Daidone MG (1993) Review of proliferative variables and their predictive value. In Recent Results in Cancer Research. Senn H, Gelber R, Goldhirsch A and Thürlimann B (eds), pp. 71-77. Springer: Heidelberg
32. Yu G, Ahmad S, Aquino A, Fairchild CR, Trepel JB, Ohno S, Suzuki K, Tsuruo T, Cowan KH and Glazer RI (1991) Transfection with protein kinase C alpha confers increased multidrug resistance to MCF-7 cells expressing P-glycoprotein. Cancer Commun 3: 181-189